BP-C2

DRUG2 trials

Sponsors

Meabco A/S, Meddoc

Conditions

Metastatic Pancreatic CancerProstate CancerUnresectable Pancreatic Cancer

Phase 1

Recommended Dose Estimation of BP-C2

RecruitingNCT04186585

MeddocProstate Cancer

Start: 2023-04-01End: 2025-09-30Target: 8Updated: 2025-05-09

Phase 2

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

CompletedNCT03627390

Meabco A/SMetastatic Pancreatic Cancer, Unresectable Pancreatic Cancer

Start: 2014-12-19End: 2016-03-04Updated: 2018-11-15